News & Updates

Nearly one in four patients with systemic lupus erythematosus (SLE) suffer a disease flare during dialysis, with most having haematological manifestations such as thrombocytopaenia, a study has shown.

The benefit of deucravacitinib in moderate to severe plaque psoriasis was demonstrated in a population of Asian patients, according to results of the phase III POETYK PSO-3 trial.

In the phase II TRAIL1 trial, oral pirfenidone slowed the rate of decline in lung function in individuals with rheumatoid arthritis-associated interstitial lung disease (RA-ILD).

Despite being vaccinated against COVID-19, women with gout have an excess risk of developing SARS-CoV-2 infection as well as severe sequelae from it, according to a study.

Symptomatic adverse events (AEs) are common and troublesome for many patients with rheumatoid arthritis (RA) who are taking medications for their condition, results of an exploratory study have shown.

Men with anticitrullinated peptide antibody (ACPA)-negative early rheumatoid arthritis (RA) tend to have favourable clinical outcomes than their female counterparts, a study has shown. However, such benefit is not seen in those with ACPA-positive early RA.

The presence of dactylitis in patients with axial psoriatic arthritis (axPsA) may result in higher disease activity and more severe joint damage compared to those without, reports a study.

Low levels of sodium intake appear to worsen bone mineral density (BMD) and aggravate the risk of osteoporosis, a recent study has found.